For research use only. Not for therapeutic Use.
Mafenide Hydrochloride(Cat No.:I001480)is a sulfonamide antibiotic primarily used as a topical agent for preventing bacterial infections in severe burn wounds. By inhibiting dihydropteroate synthase, it disrupts folic acid synthesis in bacteria, which is crucial for bacterial growth and replication. Known for its effectiveness against Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa, Mafenide Hydrochloride is valuable in preventing and treating wound infections in burn patients. Its role in infection control has made it a key treatment in burn care, helping reduce infection-related complications and improve healing outcomes.
Catalog Number | I001480 |
CAS Number | 138-37-4 |
Molecular Formula | C7H11ClN2O2S |
Purity | ≥95% |
Target | Antibacterial |
Solubility | 10 mM in H2O |
Storage | Store at -20°C |
IUPAC Name | 4-(aminomethyl)benzenesulfonamide;hydrochloride |
InChI | InChI=1S/C7H10N2O2S.ClH/c8-5-6-1-3-7(4-2-6)12(9,10)11;/h1-4H,5,8H2,(H2,9,10,11);1H |
InChIKey | SIACJRVYIPXFKS-UHFFFAOYSA-N |
SMILES | C1=CC(=CC=C1CN)S(=O)(=O)N.Cl |
Reference | <p style=/line-height:25px/> <br>[2]. Haynes, B.W., Jr., Mafenide acetate in burn treatment. N Engl J Med, 1971. 284(23): p. 1324. <br>[3]. Haik, J., et al., Burn care standards in Israel: lack of consensus. Burns, 2005. 31(7): p. 845-9. </p> |